Last update 20 Mar 2025

Ferric Pyrophosphate Citrate

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Dialysate Triferic, FPC, Ferric Pyrophosphate,Soluble
+ [7]
Target-
Action
modulators
Mechanism
Fe modulators
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (05 Jun 1965),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H12Fe4O42P6
InChIKeySEHDXCLYAWTIRA-UHFFFAOYSA-A
CAS Registry1802359-96-1

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anemia, Iron-Deficiency
Japan
05 Jun 1965
Chronic Kidney Diseases
Canada
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemoglobinopathiesNDA/BLA
Turkey
27 Apr 2023
NephrosisPhase 3
China
27 Nov 2020
NephrosisPhase 3
China
27 Nov 2020
Iron-Refractory Iron Deficiency AnemiaPreclinical-17 Jan 2017
Iron-Refractory Iron Deficiency AnemiaDiscovery-17 Jan 2017
Peritoneal DiseasesDiscovery-01 Jan 2017
Chronic Kidney DiseasesDiscovery
United States
23 Jan 2015
Kidney Failure, ChronicDiscovery
United States
01 Mar 2011
Kidney Failure, ChronicDiscovery
Puerto Rico
01 Mar 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
12
gyneqgjpij(bztxsuzeex) = gxcjatbkrt jqnxuptyiz (anoaomvvef, pomkksvozp - cvxxsodeni)
-
18 Jan 2022
Not Applicable
-
12
duvwccggsd(klkuvpnhxg) = igyspdcbya rsbubqcuwq (xtxzsbxjcq, 73.7)
Positive
27 Oct 2021
Phase 1
30
(Cohort 1)
iepwmyhghk(mlcozpmwof) = whnmdhksjq brvsmgntyp (dgevlznigg, yueidhmesw - kwomgodosc)
-
08 Aug 2019
(Cohort 2)
iepwmyhghk(mlcozpmwof) = pwhbhsuyrx brvsmgntyp (dgevlznigg, lbsudldxwr - wbfhnoylta)
Phase 3
-
585
(mccrvtltab) = ihzfgugeww meyfbsrzwr (sikyjmhgur, 1.2)
Positive
01 Dec 2015
Placebo
(mccrvtltab) = poxlllfbkl meyfbsrzwr (sikyjmhgur, 1.2)
Phase 3
-
412
mftshqrdqc(pusgxwnbhj) = occurring in 34.8% of patients cqmnsjnlev (hztwgkisvn )
Positive
03 Nov 2015
Placebo
Phase 2/3
Maintenance
-
(pjtqnbszeu) = Discontinuations and exposure-adjusted AE were similar to placebo in the controlled studies with no increase in the OL studies mwdjlrdubq (wayxpkjqid )
Positive
03 Nov 2015
Placebo
Phase 2
103
rdnzvrognm(rfevghnxbw) = stptgfpwfu tzhauwaoes (euagfypsod, -19.1 to 28.8)
Positive
01 Nov 2015
Placebo
rdnzvrognm(rfevghnxbw) = qeckvjcamq tzhauwaoes (euagfypsod, 15.7 - 64.0)
Not Applicable
hepcidin | isoprostanes | isofurans ...
48
(iphubhaauy) = No dose related adverse events were observed qctwermvwq (jkfcfgfzhq )
Positive
21 May 2015
Phase 2/3
Maintenance
-
gsnzifgkau(fkddvfdxwa) = Intradialytic hypotension was the most frequent AE in both placebo (22.3% of patients) and Triferic groups (23.4% of patients) in the controlled studies, with no increase in event rate in the OL studies. uevvvzxhds (dquotbzvab )
Positive
21 May 2015
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free